Crossmark

Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study

Published Online: 2019-05-22

Published Print: 2019-07

Authors

Hengerer, Fritz H.

Auffarth, Gerd U.

Riffel, Christoffer

Conrad-Hengerer, Ina
Funding

Funding for this research was provided by:

Glaukos Corporation (Publishing fees, editorial assistance.)
License Information

Text and Data Mining valid from 2019-05-22

Version of Record valid from 2019-05-22
More Information

Article History

Received: 13 March 2019

First Online: 22 May 2019

Document is current